Advertisement

Advertisement

How Congress, the FDA, and Sarah Jessica Parker Helped EpiPen Become a $1 Billion Business

EpiPen, the life-saving allergy product, is now a $1 billion a year business for Mylan, a drug company that’s currently enduring a wave of bad publicity over the extraordinary surge in EpiPen pricing. In 2007, an EpiPen cost about $57. Today that price has skyrocketed to over $600—all for about $1 worth of injectable…